Postvaccination Miller Fisher syndrome

Archives of Neurology

Volumn 68, Issue 10, 2011, Pages 1325-1327

  Shoamanesh, Ashkan ^a   Chapman, Kristine ^a   Traboulsee, Anthony ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; INFLUENZA VACCINE;

AGED; ANISOCORIA; AREFLEXIA; ARTICLE; ATAXIA; BRAIN ISCHEMIA; CASE REPORT; DIPLOPIA; DYSESTHESIA; FEMALE; GUILLAIN BARRE SYNDROME; HUMAN; LATENT PERIOD; NAUSEA; NERVE CONDUCTION; NUCLEAR MAGNETIC RESONANCE IMAGING; OPHTHALMOPLEGIA; PRIORITY JOURNAL; PTOSIS; SENSORY NEUROPATHY; UNSTEADINESS; IMMUNOLOGY; INFLUENZA; REVIEW; ANAMNESIS; CEREBROSPINAL FLUID ANALYSIS; CHINESE; CLINICAL FEATURE; HAPLOTYPE; INFLUENZA A (H1N1); LEUKOCYTE COUNT; PROTEIN CEREBROSPINAL FLUID LEVEL; VACCINATION REACTION;

AGED; FEMALE; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MILLER FISHER SYNDROME;

EID: 80053910497     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneurol.2011.236     Document Type: Article

References (22)

1. Brown PK. Early vaccination controversy with an original letter by Jenner. Cal State J Med. 1914;12(5):172-177.
2. Willison HJ, Yuki N. Peripheral neuropathies and anti-glycolipid antibodies. Brain. 2002;125(pt 12):2591-2625. (Pubitemid 35423511)
3. Mori M, Kuwabara S, Fukutake T, Yuki N, Hattori T. Clinical features and prognosis of Miller Fisher syndrome. Neurology. 2001;56(8):1104-1106. (Pubitemid 32336323)
4. Fisher M. An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia and areflexia). N Engl J Med. 1956;255(2):57-65.
5. Chiba A, Kusunoki S, Shimizu T, Kanazawa I. Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome. Ann Neurol. 1992;31(6):677-679.
6. Tan H, Caner I, Deniz O, Büyükavci M. Miller Fisher syndrome with negative anti- GQ1b immunoglobulin G antibodies. Pediatr Neurol. 2003;29(4):349-350. (Pubitemid 37476241)
7. Blanco-Marchite CI, Buznego-Suárez L, Fagúndez-Vargas MA, Méndez-Llatas M, Pozo-Martos P. Miller Fisher syndrome, internal and external ophthalmoplegia after flu vaccination. Arch Soc Esp Oftalmol. 2008;83(7):433-435.
8. Thaler A. Miller Fisher syndrome in a 66-year-old female after flu and pneumovax vaccinations. J Am Med Dir Assoc. 2008;9(4):283-284. (Pubitemid 351780142)
9. Breman JG, Hayner NS. Guillain-Barré syndrome and its relationship to swine influenza vaccination in Michigan, 1976-1977. Am J Epidemiol. 1984;119(6):880-889. (Pubitemid 14124206)
10. Schonberger LB, Bregman DJ, Sullivan-Bolyai JZ, et al. Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976-1977. Am J Epidemiol. 1979;110(2):105-123. (Pubitemid 10209694)
11. Hurwitz ES, Schonberger LB, Nelson DB, Holman RC. Guillain-Barré syndrome and the 1978-1979 influenza vaccine. N Engl J Med. 1981;304(26):1557- 1561. (Pubitemid 11122502)
12. Kaplan JE, Schonberger LB, Hurwitz ES, Katona P. Guillain-Barré syndrome in the United States, 1978-1981: additional observations from the national surveillance system. Neurology. 1983;33(5):633-637. (Pubitemid 13080456)
13. Roscelli JD, Bass JW, Pang L. Guillain-Barré syndrome and influenza vaccination in the US Army, 1980-1988. Am J Epidemiol. 1991;133(9):952-955.
14. Lasky T, Terracciano GJ, Magder L, et al. The Guillain-Barré syndrome and the 1992-1993 and 1993-1994 influenza vaccines. N Engl J Med. 1998;339(25):1797-1802. (Pubitemid 29005783)
15. Souayah N, Nasar A, Suri MF, Qureshi AI. Guillain-Barré syndrome after vaccination in United States: data from the Centers for Disease Control and Prevention/Food and Drug Administration Vaccine Adverse Event Reporting System (1990-2005). J Clin Neuromuscul Dis. 2009;11(1):1-6.
16. Vellozzi C, Broder KR, Haber P, et al. Adverse events following influenza A (H1N1) 2009 monovalent vaccines reported to the Vaccine Adverse Event Reporting System, United States, October 1, 2009-January 31, 2010. Vaccine. 2010;28(45):7248-7255.
17. Centers for Disease Control and Prevention (CDC). Preliminary results: surveillance for Guillain-Barré syndrome after receipt of influenza A (H1N1) 2009 monovalent vaccine - United States, 2009-2010.MMWRMorb Mortal Wkly Rep. 2010;59(21):657-661.
18. Toplak N, Kveder T, Trampus-Bakija A, Subelj V, Cucnik S, Avcin T. Autoimmune response following annual influenza vaccination in 92 apparently healthy adults. Autoimmun Rev. 2008;8(2):134-138.
19. Ziegler DW, Gardner JJ, Warfield DT, Walls HH. Experimental allergic neuritislike disease in rabbits after injection with influenza vaccines mixed with gangliosides and adjuvants. Infect Immun. 1983;42(2):824-830. (Pubitemid 14230286)
20. Nachamkin I, Shadomy SV, Moran AP, et al. Anti-ganglioside antibody induction by swine (A/NJ/1976/H1N1) and other influenza vaccines: insights into vaccineassociated Guillain-Barré syndrome. J Infect Dis. 2008;198(2):226-233. (Pubitemid 352019288)
21. Hjorth RN, Bonde GM, Piner E, Hartzell RW, Rorke LB, Rubin BA. Experimental neuritis induced by a mixture of neural antigens and influenza vaccines: a possible model for Guillain-Barré syndrome. J Neuroimmunol. 1984;6(1):1-8. (Pubitemid 14132679)
22. Collet JP, MacDonald N, Cashman N, Pless R; Advisory Committee on Causality Assessment. Monitoring signals for vaccine safety: the assessment of individual adverse event reports by an expert advisory committee. Bull World Health Organ. 2000;78(2):178-185. (Pubitemid 30151602)